Metabolite

KNApSAcK Entry

id C00036782
Name Parmelin / Atranorin / Usnarin acid
CAS RN 479-20-9
Standard InChI InChI=1S/C19H18O8/c1-8-5-12(21)11(7-20)17(23)15(8)19(25)27-13-6-9(2)14(18(24)26-4)16(22)10(13)3/h5-7,21-23H,1-4H3
Standard InChI (Main Layer) InChI=1S/C19H18O8/c1-8-5-12(21)11(7-20)17(23)15(8)19(25)27-13-6-9(2)14(18(24)26-4)16(22)10(13)3/h5-7,21-23H,1-4H3

Cluster

Phytochemical cluster
KCF-S cluster No. 3861

Link

ChEMBL

By standard InChI CHEMBL173395
By standard InChI Main Layer CHEMBL173395

KEGG

By LinkDB

CTD

By CAS RN C026304

Human Protein / Gene in interaction

2 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P18031 Tyrosine-protein phosphatase non-receptor type 1 Tyr CHEMBL173395 CHEMBL1036431 (1)
0 / 0
P08684 Cytochrome P450 3A4 Cytochrome P450 3A4 CHEMBL173395 CHEMBL1614108 (1) CHEMBL1613886 (1)
0 / 1

CTD interaction (5)

compound gene gene name gene description interaction interaction type form reference
pmid
C026304 581 BAX
BCL2L4
BCL2-associated X protein atranorin results in decreased expression of BAX protein decreases expression
protein 22285236
C026304 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 atranorin results in decreased expression of BCL2 protein decreases expression
protein 22285236
C026304 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 atranorin results in decreased expression of BCL2L1 protein decreases expression
protein 22285236
C026304 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) atranorin results in increased activity of CASP3 protein increases activity
protein 22285236
C026304 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 atranorin results in decreased expression of TP53 protein decreases expression
protein 22285236

Related Disease

Diseases related to proteins in ChEMBL interactions

KEGG DISEASE (1)

KEGG disease name UniProt
H00036 Osteosarcoma P08684 (marker)

Diseases related to CTD interactions

3 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D005157 C026304 Facial Pain therapeutic
21138055
D007249 C026304 Inflammation therapeutic
21138055
D009369 C026304 Neoplasms therapeutic
22285236